TOVX
Theriva Biologics·AMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TOVX Filings
Filing Date
Form Description
Form Type
2025-12-03
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-03 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-03
Form EFFECT - Notice of Effectiveness
2025-12-03 ·
Form EFFECT - Notice of Effectiveness
2025-11-12
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Key Events
2025-11-12 · Key Events
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2025-11-12
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-12 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-12
Form 8-K - Current report
Key Events
2025-11-12 · Key Events
Form 8-K - Current report
2025-11-10
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-10 ·
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2025-11-10
Form DEF 14A - Other definitive proxy statements
Key Events
2025-11-10 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-11-07
Form S-3 - Registration statement under Securities Act of 1933
2025-11-07 ·
Form S-3 - Registration statement under Securities Act of 1933
2025-10-31
Form PRE 14A - Other preliminary proxy statements
Key Events
2025-10-31 · Key Events
Form PRE 14A - Other preliminary proxy statements
2025-10-29
Form 8-K - Current report
Key Events
2025-10-29 · Key Events
Form 8-K - Current report
